About Covalent Laboratories Private Limited
Data last updated:
Covalent Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 13 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2002PTC039606. Its GSTIN is 36AABCC9544R1ZY (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Madireddy Narayana Reddy (Managing Director) and Abhinav Reddy Nandigala (Whole-Time Director).
Its last annual general meeting (AGM) was held on 31 July 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No.8 – 3 – 677/18 S.K.D.Nagar Yellareddyguda, Hyderabad, Telangana, India – 500073.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,693.24 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹174.45 Cr (net margin 6.5%) and EBITDA of ₹280.41 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
The company has about 860 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Covalent Laboratories. As per MCA filings, the company has open charges of ₹1,674.23 Cr and satisfied charges of ₹279.5 Cr on record. Court records list 67 cases involving the company, including 55 filed by the company and 12 filed against it; 32 cases are pending. The company has 6 deals on record (6 secondary share transfers); the latest was in May 2020. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Granules India Limited with revenue of ₹4,494.53 Cr. The company has 16 MSME Form 1 returns on record between 2019 and 2024, listing 223 overdue payments to 39 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website covalentlab.com.
Company details
CIN history
Covalent Laboratories has one previous CIN (Corporate Identification Number): U24230AP2002PTC039606. The current CIN is U24230TG2002PTC039606, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2002PTC039606 | Current |
| U24230AP2002PTC039606 | Previous |
Contact details
Covalent Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is covalentlab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD.No.8 – 3 – 677/18 S.K.D.Nagar Yellareddyguda, Hyderabad, Telangana, India – 500073
- IndustryPharma, API Manufacturers
To see the full contact details of Covalent Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Covalent Laboratories operates one associated brand: Covalent Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in manufacturing Cephalosporins and APIs for Indian and international markets. | covalentlab.com |
Business activity
The main business activity of Covalent Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Covalent Laboratories Private Limited, buy the company report.
Financials of Covalent Laboratories Private Limited
FY 2024 filings availableCovalent Laboratories Private Limited reported revenue of ₹2,693.24 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹280.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹174.45 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 6.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Covalent Laboratories Private Limited, buy the company report.
Board of directors of Covalent Laboratories Private Limited
Covalent Laboratories has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhinav Reddy Nandigala | Whole-Time Director | 19 Oct 2023 | 3 Years 0 Months | Current |
| Madireddy Narayana Reddy | Managing Director | 13 Sep 2002 | 24 Years 1 Months | Current |
| Prasanth Nandigala Also directs: Ceph Lifesciences Private Limited, Pokarna Limited, Virchow Agrochemicals Private Limited and 5 more | Director | 15 May 2003 | 23 Years 5 Months | Current |
| Maddireddy Vijaykiran Also directs: Vaki Clean Energy LLP, Ceph Lifesciences Private Limited | Whole-Time Director | 13 Sep 2002 | 24 Years 1 Months | Current |
| Mundla Maha Vishnu Also directs: Ceph Lifesciences Private Limited, Virchow Petrochemical Private Limited, Andhra Organics Limited and 5 more | Additional Director | 01 Oct 2024 | 2 Years 0 Months | Current |
Peer comparison
Covalent Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Granules India Limited | ₹4,494.53 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Matrix Pharmacorp Private Limited | ₹4,422.21 Cr (FY 2025) | 16378466.0% | Sangareddy, Telangana, India | |||
| Cadila Pharmaceuticals Limited | ₹3,869.17 Cr (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Hetero Drugs Limited | ₹3,323.92 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India | |||
| Dishman Carbogen Amcis Limited | ₹2,733.18 Cr (FY 2025) | 3.0% | Ahmedabad, Gujarat, India | |||
| Covalent Laboratories Private Limitedthis company | ₹2,693.24 Cr (FY 2025) | ₹174.45 Cr | 6.5% | -8.0% | 860 | Hyderabad, Telangana, India |
| Honour Lab Limited | ₹2,482.63 Cr (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Alivus Life Sciences Limited | ₹2,421.45 Cr (FY 2025) | 5.0% | Solapur, Maharashtra, India | |||
| Aarti Drugs Limited | ₹2,403.39 Cr (FY 2025) | -5.0% | Thane, Maharashtra, India | |||
| Centrient Pharmaceuticals India Private Limited | ₹2,240.1 Cr (FY 2025) | 8.0% | Toansa, Punjab, India | |||
| Unichem Laboratories Limited | ₹2,146.29 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Covalent Laboratories Private Limited, buy the company report.
Auditor
Covalent Laboratories Private Limited is audited by Surya Narayana Reddy & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Surya Narayana Reddy & Co | FY 2024 | 005752S |
Shareholding
The shareholding of Covalent Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Covalent Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101163592 | Sbicap Trustee Company Limited | ₹850 Cr | Open | |
| 18 Jun 2022 | 100594634 | Citi Bank N.A. | ₹30 Cr | Open | |
| 20 Feb 2020 | 100330203 | Others | ₹50 Cr | Open | |
| 04 Feb 2019 | 100239647 | Others | ₹285 Cr | Open | |
| 28 Nov 2015 | 10609039 | Hdfc Bank Limited | ₹63 Cr | Open |
To see the full charge records of Covalent Laboratories Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Covalent Laboratories Private Limited has 6 deals on record (6 secondary share transfers); the latest was in May 2020.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2020 | Secondary share transfer | Undisclosed | Buyer: Virchow Petrochemicals Private Limited, 3 individuals Seller: 4 individuals |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: Virchow Petrochemicals Private Limited, 3 individuals Seller: 4 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Covalent Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Covalent Laboratories Private Limited has 67 court cases on record: 55 filed by Covalent Laboratories, 12 filed against it. 32 cases are pending and 35 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 47 | 7 | 25 |
| High courts | 20 | 5 | 7 |
Cases on record (5 of 67)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed by the company against Delius Pharmaceuticals Pvt. Ltd., Rep. by Mr. Digvijay Kumar Srivastava | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Dipna Pharmachem Ltd., and 1 other | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Twenty First Century Pharmaceuticals Pvt. Ltd. | Pending |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against M/S. Ang Life Sciences Pvt Ltd Rep by Rajesh Gupta | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against M/S. Vexta Laboratories Pvt. Ltd. | Disposed |
To see the full case history of Covalent Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Covalent Laboratories Private Limited was last rated by Icra on 06 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 06 Oct 2021 |
To see the full credit ratings and regulatory alerts of Covalent Laboratories Private Limited, buy the company report.
MSME payment delays
Covalent Laboratories Private Limited has 16 MSME Form 1 returns on record between 2019 and 2024, listing 223 overdue payments to 39 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 39)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Allied Chemical and Equipment | |||
| an individual supplier | |||
| Dudhani Poly-Extrusions Private Limited | |||
| an individual supplier | |||
| SKC Chemie Private Limited |
To see the full MSME payment records of Covalent Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Covalent Laboratories Private Limited has a workforce of 860 employees on its EPFO records as of Nov 28, 2025, across 1 active EPFO establishment.
GST
Covalent Laboratories has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCC9544R1ZY | Telangana | Active | 01 Jul 2017 |
| 37AABCC9544R2ZV | Andhra Pradesh | Active | 11 Dec 2024 |
To see the full GST registrations and return filing status of Covalent Laboratories Private Limited, buy the company report.
Recent activity
Covalent Laboratories Private Limited has 9 board changes on record since 2002: 5 appointments and 4 cessations. The latest: Narayana Reddy Mundla ceased to be Director on 21 Dec 2024.
39 earlier events are in the company report.
Frequently asked questions
Covalent Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 13 September 2002 (24+ years old) and is registered under CIN U24230TG2002PTC039606.
Covalent Laboratories has 5 current directors:
- Madireddy Narayana Reddy - Managing Director
- Abhinav Reddy Nandigala - Whole-Time Director
- Maddireddy Vijaykiran - Whole-Time Director
- Prasanth Nandigala - Director
- Mundla Maha Vishnu - Additional Director
The latest financial statements of Covalent Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Covalent Laboratories is 36AABCC9544R1ZY, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AABCC9544R2ZV (Andhra Pradesh).
The CIN (Corporate Identification Number) of Covalent Laboratories is U24230TG2002PTC039606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Covalent Laboratories has 67 court cases on record: 55 filed by the company and 12 filed against it. 32 are pending. Most are in the district courts.
Covalent Laboratories was incorporated on 13 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
Covalent Laboratories has 6 deals on record (6 secondary share transfers); the latest was in May 2020.
The peers of Covalent Laboratories by revenue are Granules India Limited, Matrix Pharmacorp Private Limited, Cadila Pharmaceuticals Limited, Hetero Drugs Limited, Dishman Carbogen Amcis Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Narayana Reddy Mundla ceased to be Director on 21 Dec 2024. Mundla Maha Vishnu was appointed as Additional Director on 01 Oct 2024. Abhinav Reddy Nandigala ceased to be Additional Director on 31 Jan 2024. Covalent Laboratories has 9 board changes on record in total.
Covalent Laboratories has 16 MSME Form 1 returns on record between 2019 and 2024, listing 223 overdue payments to 39 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Covalent Laboratories can be reached through the website covalentlab.com. Its registered office is in Hyderabad, Telangana, India.